ADAM12 and breast carcinoma: As Luminal B tumors are estrogen receptor-positive [36], [37], these results, together with our functional analysis of ADAM12 breast cancer-related mutants presented here, collectively suggest that ADAM12 may play fundamentally different roles in TNBCs and in non-TNBC.